Docetaxel-associated radiation recall dermatitis

Current Oncology

Volumn 9, Issue 2, 2002, Pages 48-51

  Mulder, K E ^a   Severin, D ^a   Tonkin, K ^a   Scarfe, A G ^a   Koski, S L ^a   Mackey, J R ^a  

^a CROSS CANCER INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DOCETAXEL; TRASTUZUMAB;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHEMA; FEMALE; HUMAN; RADIATION RECALL DERMATITIS; RADIOSENSITIZATION; RECURRENT DISEASE; SKIN INFLAMMATION; SKIN MANIFESTATION;

EID: 0036619721     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Letter: Adriamycin activating a recall phenomenon after radiation therapy
2. Potentials of X-ray effects of actinomycin D
3. Taxol and radiation recall dermatitis
4. Paclitaxel and radiation-recall dermatitis
5. Radiation-recall dermatitis in a patient treated with paclitaxel
6. Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel
7. Paclitaxel-induced radiation recall dermatitis
8. Paclitaxel induced radiation recall dermatitis
9. Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence
10. Radiation recall dermatitis with docetaxel: Establishment of a requisite radiation threshold
11. Challenges in oncology. Case 2. Radiation recall associated with docetaxel
12. Characterizing the phenomenon of radiation recall dermatitis
13. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
14. The taxanes: An update